Á lódáil...

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma

PURPOSE: NRG Oncology/RTOG 9802 (ClinicalTrials.gov Identifier: NCT00003375) is a practice-changing study for patients with WHO low-grade glioma (LGG, grade II), as it was the first to demonstrate a survival benefit of adjuvant chemoradiotherapy over radiotherapy. This post hoc study sought to deter...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:J Clin Oncol
Main Authors: Bell, Erica H., Zhang, Peixin, Shaw, Edward G., Buckner, Jan C., Barger, Geoffrey R., Bullard, Dennis E., Mehta, Minesh P., Gilbert, Mark R., Brown, Paul D., Stelzer, Keith J., McElroy, Joseph P., Fleming, Jessica l., Timmers, Cynthia D., Becker, Aline P., Salavaggione, Andrea L., Liu, Ziyan, Aldape, Kenneth, Brachman, David G., Gertler, Stanley Z., Murtha, Albert D., Schultz, Christopher J., Johnson, David, Laack, Nadia N., Hunter, Grant K., Crocker, Ian R., Won, Minhee, Chakravarti, Arnab
Formáid: Artigo
Teanga:Inglês
Foilsithe: American Society of Clinical Oncology 2020
Ábhair:
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7527157/
https://ncbi.nlm.nih.gov/pubmed/32706640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.02983
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!